U.S. FDA

FDA Officials Wrestle with CBD in Day-Long Meeting on Science “Challenges”

The FDA still has more questions than answers on CBD, but it is making strides on conducting the research and collecting the data needed to release product regulations.

Regulation
New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.